Actively Recruiting
Reduction of Bacterial Seeding in Total Shoulder Arthroplasty: Prontosan Antimicrobial Gel Incision Preparation Versus No Preparation in Male Patients
Led by St. Louis University · Updated on 2026-03-10
60
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
Sponsors
S
St. Louis University
Lead Sponsor
I
Innovice, LLC
Collaborating Sponsor
AI-Summary
What this Trial Is About
This research aims to compare the growth of Cutibacterium Acnes bacteria in tissue samples taken during primary shoulder replacement surgery. The study focuses on male patients undergoing elective anatomic or reverse total shoulder arthroplasty for conditions like massive rotator cuff tears, rotator cuff arthropathy, osteoarthritis, or acute fractures. Researchers want to see if applying an antimicrobial gel after the skin incision reduces bacterial presence compared to no additional skin preparation after incision. The study will enroll 60 male participants who will be randomly assigned to one of two groups: one group will receive standard pre-operative antibiotics and skin preparation but no further skin treatment after incision, while the other group will have Prontosan Wound Gel applied to the dermal layer after the incision is made. Both groups will have the same antibiotic and irrigation protocols. During surgery, after the final implant is placed and before closing the wound, multiple tissue cultures will be taken to check for bacterial growth. Participants will be monitored by collecting two deep tissue cultures, two superficial tissue cultures, and one implant culture during surgery. These samples will be analyzed in the lab for up to two weeks to detect bacterial growth. The main outcome measured is the number of positive bacterial cultures after 14 days. The study will take place starting in February 2026 with follow-up focused on infection monitoring during and after surgery.
CONDITIONS
Brief Title
Reduction of Bacterial Seeding in Total Shoulder Arthroplasty
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adult male 18 years of age or older
- Undergoing elective primary total shoulder arthroplasty, including anatomic or reverse procedures
- Surgery for massive rotator cuff tears, rotator cuff arthropathy, glenohumeral osteoarthritis, or acute fractures
You will not qualify if you...
- Any revision shoulder arthroplasty or other shoulder surgery not primary
- Allergy to active ingredients in Prontosan gel
- Unable to consent for themselves
- Non-English speaking
- Female gender
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Day of surgery
Participants undergo primary total shoulder arthroplasty surgery with assigned dermal incision preparation during the procedure.
1 surgery visit (in-person)
Trial Site Locations
Total: 1 location
1
Saint Louis University
St Louis, Missouri, United States, 63110
Actively Recruiting
Research Team
R
Randall Otto, MD
A
Allison Gruender, RN, MSN
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here